Zenas Biopharma, INC. (ZBIO) SEC Filings — 2025

Filings

• Zenas BioPharma Announces Board and Executive Changes — 8-K · Dec 15, 2025
• Zenas BioPharma Files 8-K on Financials — 8-K · Nov 12, 2025
• Zenas BioPharma Files 8-K Report — 8-K · Oct 27, 2025
• Zenas BioPharma Files 8-K: Agreements, Financials, Equity Sales — 8-K · Oct 8, 2025
• Zenas BioPharma Completes Asset Acquisition from 03 Life Sciences — 8-K · Sep 2, 2025
• Zenas BioPharma Files 8-K on Financials — 8-K · Aug 12, 2025
• Zenas BioPharma's Losses Widen Amid Soaring R&D, Cash Drains — 10-Q · Aug 12, 2025
• Zenas BioPharma Announces Board and Executive Changes — 8-K · Jun 12, 2025
• Zenas BioPharma Files 8-K Report — 8-K · Jun 4, 2025
• Zenas BioPharma Files 8-K on Operations and Financials — 8-K · May 15, 2025
• Zenas BioPharma Files 10-Q, Details Xencor & Viridian Ties — 10-Q · May 15, 2025
• Zenas BioPharma Files Annual Proxy Statement — DEF 14A · Apr 28, 2025
• Zenas BioPharma Files 2024 10-K, Reports $81M R&D Spend — 10-K · Mar 11, 2025
• Zenas BioPharma Files 8-K on Financials — 8-K · Feb 5, 2025